Article
[Cancer genome analysis through next-generation sequencing].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Jan 2011
Aburatani Hiroyuki
Abstract excerpt
Cancers are caused by the accumulation of genomic and epigenomic alterations. Particularly, genetic alterations, such as BCR-ABL translocation and EGFR mutation, which are present only in cancer cells, are the best therapeutic targets to date. The application of next-generation DNA sequencing technologies, including whole-genome, whole-exome and whole-transcriptome approaches, has brought substantial advances in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
